Substituted tetrahydropyrroloquinolines

Details for Australian Patent Application No. 2008228566 (hide)

Owner Merck Patent GmbH

Inventors Enderle, Holger

Agent Davies Collison Cave

Pub. Number AU-A-2008228566

PCT Pub. Number WO2008/113452

Priority 10 2007 013 856.5 20.03.07 DE

Filing date 21 February 2008

Wipo publication date 25 September 2008

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

26 November 2009 PCT application entered the National Phase

  PCT publication WO2008/113452 Priority application(s): WO2008/113452

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008228570-Tetrahydroquinoline derivatives and use of same for treating cancer

2008228565-Substituted tetrahydroquinolines